Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)
Clinical trial NCT04614051 · TERMINATED
Trial details
- NCT number
- NCT04614051
- Sponsor
- Pharmicell Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2022-05-10
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.